Multitargeted receptor tyrosine kinase inhibition: An antiangiogenic strategy in non-small cell lung cancer-Reference-Cited by-同舟云学术

Multitargeted receptor tyrosine kinase inhibition: An antiangiogenic strategy in non-small cell lung cancer

Published:2011-12 Issue:8 Volume:37 Page:611-617
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Socinski Mark A.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference85 articles.

1. Cancer Statistics, 2010;Jemal;CA Cancer J Clin,2010

2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology™. Non-Small Cell Lung Cancer. V.2.2010. Available from: http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf [accessed 8.4.2010].

3. Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions;Ramalingam;Oncologist,2008

4. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer;Sandler;N Engl J Med,2006

5. Clinical evidence for second- and third-line treatment options in advanced non-small cell lung cancer;de Marinis;Oncologist,2008

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variations in the Profiles of Vascular-Related Factors Among Different Sub-Types of Polycystic Ovarian Syndrome in Northern China;Frontiers in Endocrinology;2021-02-26

2. Anti-tumor Drug Targets Analysis: Current Insight and Future Prospect;Current Drug Targets;2019-08-22

3. Mapping Tyrosine Kinase Receptor Dimerization to Receptor Expression and Ligand Affinities;Processes;2019-05-15

4. Design, synthesis and preclinical evaluation of 5-methyl-N4-aryl-furo[2,3-d]pyrimidines as single agents with combination chemotherapy potential;Bioorganic & Medicinal Chemistry Letters;2018-10

5. PDGF/PDGFR effects in osteosarcoma and the “add-on” strategy;Clinical Sarcoma Research;2018-08-02